Wednesday, 23 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14475
Articles
Policy / Regulatory
Shanghai Launches Inhaled COVID-19 Vaccine Booster Program
February 2, 2025
Company
Drug
Ocumension Initiates Second Phase III Denali Study for OT-301 in US
February 2, 2025
Company
R&D
Nankai University Establishes Postgraduate Practice Base with China Resources Biopharma
February 2, 2025
Company
Deals
Yiming and WZ Biosciences Collaborate on mRNA Process Platform
February 2, 2025
Company
Drug
BeiGene’s Brukinsa Receives Multiple Marketing Approvals in Latin America
February 2, 2025
Company
Drug
Zhaoke Ophthalmology Completes Enrollment for Intrarosa Phase III Trial
February 2, 2025
Company
Deals
JW Therapeutics Partners with 2seventy bio to Develop Cell Therapy Platform
February 2, 2025
Company
Drug
Ascletis Pharma Files IND for Monkeypox Antiviral ASC10 with FDA
February 2, 2025
Company
Drug
Simcere Receives FDA Clearance for Clinical Study of SIM0237
February 2, 2025
Company
Ping An Life Insurance Reports Q3 Results, Advances Healthcare Strategy
February 2, 2025
Company
Drug
United Labs Gains NMPA Approval for Ozempic Biosimilar IND
February 2, 2025
Policy / Regulatory
China’s NMPA Issues New Drug Recall Management Measures
February 2, 2025
1
2
…
1,113
1,114
1,115
1,116
1,117
…
1,206
1,207
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
